ES2526147T3 - Ésteres de metronidazol para el tratamiento de la rosácea - Google Patents
Ésteres de metronidazol para el tratamiento de la rosácea Download PDFInfo
- Publication number
- ES2526147T3 ES2526147T3 ES11728011.5T ES11728011T ES2526147T3 ES 2526147 T3 ES2526147 T3 ES 2526147T3 ES 11728011 T ES11728011 T ES 11728011T ES 2526147 T3 ES2526147 T3 ES 2526147T3
- Authority
- ES
- Spain
- Prior art keywords
- rosacea
- treatment
- metronidazole esters
- metronidazole
- esters
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
- C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Compuesto seleccionado a partir del compuesto de fórmula (I) siguiente:**Fórmula** y una de sus sales farmacéuticamente aceptables.
Description
Claims (1)
-
imagen1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1055244A FR2961811B1 (fr) | 2010-06-29 | 2010-06-29 | Esters de metronidazole pour traiter la rosacee |
FR1055244 | 2010-06-29 | ||
PCT/EP2011/060925 WO2012001055A1 (en) | 2010-06-29 | 2011-06-29 | Metronidazole esters for treating rosacea |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2526147T3 true ES2526147T3 (es) | 2015-01-07 |
Family
ID=42797343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES11728011.5T Active ES2526147T3 (es) | 2010-06-29 | 2011-06-29 | Ésteres de metronidazol para el tratamiento de la rosácea |
Country Status (7)
Country | Link |
---|---|
US (1) | US8796325B2 (es) |
EP (1) | EP2588461B1 (es) |
JP (1) | JP2013529669A (es) |
CA (1) | CA2801991A1 (es) |
ES (1) | ES2526147T3 (es) |
FR (1) | FR2961811B1 (es) |
WO (1) | WO2012001055A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2991682T3 (en) * | 2013-04-30 | 2017-07-10 | Claus Selch Larsen | PRODRUGS OF NAPROXEN AND DICLOFENAC |
CN105348200B (zh) * | 2015-12-23 | 2018-09-25 | 武汉武药制药有限公司 | 一种甲硝唑合成方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0127274A3 (en) * | 1983-03-25 | 1987-05-20 | The Upjohn Company | Esters of metronidazole and compositions containing them |
IL142037A0 (en) * | 2001-03-15 | 2002-03-10 | Agis Ind 1983 Ltd | Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug |
US8853247B2 (en) * | 2007-11-02 | 2014-10-07 | Nektar Therapeutics | Oligomer-nitroimidazole anti-infective conjugates |
-
2010
- 2010-06-29 FR FR1055244A patent/FR2961811B1/fr not_active Expired - Fee Related
-
2011
- 2011-06-29 EP EP11728011.5A patent/EP2588461B1/en not_active Not-in-force
- 2011-06-29 CA CA2801991A patent/CA2801991A1/en not_active Abandoned
- 2011-06-29 US US13/807,167 patent/US8796325B2/en not_active Expired - Fee Related
- 2011-06-29 ES ES11728011.5T patent/ES2526147T3/es active Active
- 2011-06-29 WO PCT/EP2011/060925 patent/WO2012001055A1/en active Application Filing
- 2011-06-29 JP JP2013517273A patent/JP2013529669A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20130197048A1 (en) | 2013-08-01 |
FR2961811B1 (fr) | 2012-07-06 |
JP2013529669A (ja) | 2013-07-22 |
WO2012001055A1 (en) | 2012-01-05 |
US8796325B2 (en) | 2014-08-05 |
EP2588461A1 (en) | 2013-05-08 |
FR2961811A1 (fr) | 2011-12-30 |
EP2588461B1 (en) | 2014-11-05 |
CA2801991A1 (en) | 2012-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2634490T3 (es) | Derivados de ácido napht-2-ylacetico para tratar el sida | |
ES2643827T3 (es) | Procedimiento para la regulación del perfil del espesor de películas de soplado | |
ES2659758T3 (es) | Antagonistas de receptores de 5-HT3 | |
ES2528026T3 (es) | Sales de oxalato de ivabridina cristalino y polimorfos de los mismos | |
ES2502472T3 (es) | Composición adhesiva para su uso en un inmunosensor | |
ES2661582T3 (es) | Efecto antiinflamatorio de la celulosa microfibrilada | |
CL2012001911A1 (es) | Compuestos derivados de fumarato; composicion farmaceutica que los comprende; y su uso en el tratamiento de una enfermedad inflamatoria o neurodegenerativa. | |
CR20160007A (es) | Nuevos compuestos triciclicos | |
CR20120418A (es) | Inhibidores de virus flaviviridae | |
CR20120397A (es) | Inhibidores del virus de la hepatitis c | |
ES2525918T3 (es) | Proceso para la fabricación de Nicorandil | |
CR20170159A (es) | Nuevos compuestos tricíclicos | |
ES2641862T3 (es) | Proceso para la elaboración de inhibidores de CCR3 | |
GT200600394A (es) | Benzimidazoles sustituidos y metodos para usarlos como inhibidores de las quinasas asociadas con la tumorigenesis. | |
ES2488407T3 (es) | Preparación farmacéutica que contiene lipasa de origen bacteriano | |
GT201300214A (es) | Moduladores de los receptores de hormonas nucleares | |
CO6491060A2 (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
AR102981A1 (es) | Inhibidores de la necrosis celular y métodos de preparación de los mismos | |
CL2017000682A1 (es) | Compuestos novedosos de imidazopiridazina y su uso. | |
ES2485373T3 (es) | Compuestos que actúan en múltiples receptores de prostaglandina proporcionando una respuesta anti-inflamatoria general | |
ES2650914T3 (es) | Sales de adición de ácidos de 5alfa-hidroxi-6beta-[2-(1H-imidazol-4-il)etilamino]colestan-3beta-ol | |
CL2012003341A1 (es) | Composicion farmaceutica de administracion oral que compende bendamustina o un ester, una sal o un solvato de la misma, y un excipiente que es un agente tensioactivo no ionico e hidrofilico; combinacion farmaceutica; y su uso para el tratamiento de leucemia linfocitica cronica y el mieloma multiple, entre otras enfermedades. | |
ES2526147T3 (es) | Ésteres de metronidazol para el tratamiento de la rosácea | |
ES2611776T3 (es) | Uso de sales de tungsteno (VI) para el tratamiento de la esterilidad femenina en mamíferos no diabéticos | |
CL2012002452A1 (es) | Procedimientos para la preparacion de 2-(ciclohexilmetil)-n-{2-[(2s)-1-metilpirrolidin-2-il] etil}-1,2,3,4-tetrahidroisoquinolin-7-sulfonamida; uno de sus compuestos interemdiarios; y la preparacion del mismo. |